natgillin/translations-raw huggingface dataset:
One dose of 2 ml contains:
Jedna doza od 2 ml sadrži:
Mineral oil (Marcol 52)
Mineralno ulje (Marcol 52)
Do not mix with any other vaccine or immunological product.
Ne miješati s bilo kojim drugim cjepivom ili imunološkim proizvodom.
b) the disease to which the product is intended to confer immunity is largely absent from the territory in question.
b) je bolest, za koju je proizvod namijenjen da pruži imunost, u velikoj mjeri odsutna s odnosnog područja.>
Use sterile syringes and needles.
Upotrebljavajte sterilne štrcaljke i igle.
CONTENTS BY WEIGHT, BY VOLUME OR NUMBER OF DOSES 10 doses
SADRŽAJ PO TEŽINI, VOLUMENU ILI BROJU DOZA
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary Apart from an increase in the extent of the tissue reaction at the site of injection, no other undesirable effects have been observed.
4.10 Predoziranje (simptomi, hitni postupci, antidoti), ako je nužno Osim povećanja opsega reakcije tkiva na mjestu injiciranja, nisu uočene nikakve druge nuspojave.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Detaljne informacije o ovom veterinarsko-medicinskom proizvodu su dostupne na web stranici European Medicines Agency http://www.ema.europa.eu/.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
13. RIJEČI „SAMO ZA PRIMJENU NA ŽIVOTINJAMA“ I UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE, ako je primjenjivo
A second dose may be injected 3-4 weeks after the first injection.
Druga doza može se injicirati 3 - 4 tjedna nakon prve injekcije.
Zoetis B.V., Podružnica Zagreb za promidžbu
Hrvatska Zoetis B.V., Podružnica Zagreb za promidžbu
Each piglet of vaccinated gilts or sows should ingest a sufficient quantity of colostrum and milk.
Svaki praščić cijepljenih nazimica ili krmača trebao bi unijeti dovoljnu količinu kolostruma i mlijeka.
QUALITATIVE AND QUANTITATIVE COMPOSITION Powder:
KVALITATIVNI I KVANTITATIVNI SASTAV Prašak:
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje veterinarsko medicinski proizvod na životinjama
Mannide mono oleate (Arlacel A)
Manid monooleat (Arlacel A)
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 07/08/1998
Datum prvog odobrenja: 07/08/1998 Datum posljednjeg produljenja odobrenja: 22/08/2008
Do not use this veterinary medicinal product after the expiry date which is stated on the label.
Ne koristite veterinarsko-medicinski proizvod poslije roka valjanosti naznačenog na etiketi poslije EXP.
• Inject one dose per gilt before the first mating, or
• Injicirati jednu dozu po nazimici prije prvog parenja ili
According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended, a Member State may, in accordance with its national legislation, prohibit the manufacture, import, possession, sale, supply and/or use of immunological veterinary medicinal products on the whole or part of its territory if it is established that:
Sukladno članku 71. Direktive 2001/82/EK i Europskog Parlamenta i Vijeća s izmjenama i dopunama, države članice, u skladu s nacionalnim zakonodavstvom mogu zabraniti proizvodnju, uvoz, posjedovanje, prodaju, opskrbu i/ili primjenu imunoloških veterinarsko-medicinskih proizvoda na cijelom ili na dijelu svog teritorija ako je utvrđeno da:
Polysorbate 80 (Tween 80)
Polisorbat 80 (Tween 80)
Shelf-life after reconstitution according to directions: 1 hour.
Rok valjanosti nakon rekonstitucije prema uputama: 1 sat.
• Inject one dose per gilt or sow during each gestation at 3-6 weeks before the expected date of farrowing.
• Injicirati jednu dozu po nazimici ili krmači tijekom svake gestacije 3 - 6 tjedana prije očekivanog datuma prasenja.
• Inject one dose per boar at least every 6 months.
• Injicirati jednu dozu po nerastu barem svakih 6 mjeseci.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton label 1 x 10 doses, 1 x 50 doses, 1 x 100 doses, 10 x 10 doses, 10 x 50 doses, 10 x 100 doses
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Etiketa na kutiji 1 x 10 doza, 1 x 50 doza, 1 x 100 doza, 10 x 10 doza, 10 x 50 doza, 10 x 100 doza
Apart from an increase in the extent of the tissue reaction at the site of injection, no other undesirable effects have been observed.
Osim povećanja opsega reakcije tkiva na mjestu injiciranja, nisu uočene nikakve druge nuspojave.
Administer by intramuscular injection of 1 dose (2 ml) per pig in the neck in the area behind the ear.
Primijenite intramuskularnom injekcijom 1 doze (2 ml) po svinji u vrat u području iza uha.
For whole herd vaccination, an injection of one dose may be administered per gilt, sow and boar every 4 months.
Za cijepljenje čitavog stada treba primijeniti injekciju od jedne doze po svakoj nazimici, krmači i nerastu svaka 4 mjeseca.
The presence of maternal antibodies against Aujeszky's disease virus may have a negative influence on the result of vaccination.
Prisutnost majčinih protutijela protiv virusa bolesti Aujeszkoga može imati negativan utjecaj na rezultat cijepljenja.
* CCID50 - the quantity of virus, which infects 50 % of the cell cultures inoculated.
* CCID50 = količina virusa, koja inficira 50% inokuliranih staničnih kultura.
Therefore, the product is suitable to be used in eradication programmes against Aujeszky's disease field virus in pigs based on the presence or absence of antibodies against the gE-antigen of that virus.
Stoga je proizvod pogodan za primjenu u programima iskorjenjivanja terenskog virusa bolesti Aujeszkoga kod svinja na temelju prisutnosti ili odsutnosti protutijela protiv gE-antigena tog virusa.
Slight, transient and local reactions up to 2 cm in diameter after first vaccination and up to 5 cm after second vaccination may occur up to 50 % of the pigs.
Blage, prolazne i lokalne reakcije do 2 cm u promjeru nakon prvog cijepljenja i do 5 cm nakon drugog cijepljenja mogu se pojaviti u do 50% svinja.
Vaccination programme:
Program cijepljenja:
A transient increase in body temperature, up to about 40,5 oC and lasting for up to 2 days, may occur in a small number of pigs after vaccination.
Prolazno povišenje tjelesne temperature, do približno 40,5°C u trajanju do 2 dana, može se pojaviti u malog broja svinja nakon cijepljenja.
Camprodón s/n "la Riba" 17813 Vall de Bianya
Camprodón s/n "la Riba" 17813 Vall de Bianya Girona
The bottles are closed with a butyl rubber stopper and sealed with an aluminium cap.
Bočice su zatvorene čepom od butilne gume i zapečaćene aluminijskom kapicom.
To reconstitute the vaccine, inject 3 ml of solvent into the small vial with the powder.
Da biste rekonstituirali cjepivo, ubrizgajte 3 ml otapala u malu bočicu s praškom.
Any person intending to manufacture, import, possess, sell, supply and use Suvaxyn Aujeszky 783 + O/W must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use.
Tko namjerava proizvoditi, uvesti, posjedovati, prodavati, opskrbljivati i/ili primjenjivati Suvaxyn Aujeszky 783 + O/W mora se savjetovati s nadležnim tijelom odnosne države članice u pogledu važećih odredbi o cijepljenju prije proizvodnje, uvoza, posjedovanja, prodaje, opskrbe i/ili primjene.
Shelf life after reconstitution: Use within one hour.
EXP {mjesec/godina} Rok valjanosti poslije rekonstitucije: potrošiti u roku od sat vremena
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.
Zbrinite otpadni materijal prokuhavanjem, spaljivanjem ili uranjanjem u prikladno dezinfekcijsko sredstvo koje je nadležno tijelo odobrilo za upotrebu.
The gE- (glycoprotein E negative) characteristic of the vaccine virus makes it possible to distinguish between antibodies induced by vaccination with this product and those induced by field infection with Aujeszky's disease virus, if the vaccine is used in association with an appropriate diagnostic test.
Karakteristika virusa cjepiva gE- (glikoprotein E negativni) omogućuje razlikovanje protutijela induciranih cijepljenjem ovim proizvodom i protutijela induciranih terenskom infekcijom virusom bolesti Aujeszkoga ako se cjepivo primjenjuje uz odgovarajući dijagnostički test.
Shelf-life of the veterinary medicinal product as packaged for sale (powder): 2 years.
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju (prašak): 2 godine.
SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children.
11. POSEBNE MJERE PRI ČUVANJU Čuvati izvan pogleda i dosega djece.
Basic vaccination of fattening pigs and breeding pigs (gilts, sows and boars):
Temeljno cijepljenje tovnih svinja i rasplodnih svinja (nazimica, krmača i nerasta):
• Inject one dose per fattening pig from the age of 10 weeks.
• Injicirati jednu dozu po tovnoj svinji od 10 tjedana starosti nadalje.
One dose (2 ml) of reconstituted emulsion containing ≥ 105.2 CCID50 of live attenuated Aujeszky's disease virus strain NIA3-783 for each pig.
Jedna doza (2 ml) rekonstituirane emulzije koja sadrži ≥ 105,2 CCID50 živog, atenuiranog virusa bolesti Aujeszkoga soja NIA3-783 za svaku svinju.
Re-vaccination of breeding pigs (gilts, sows and boars):
Revakcinacija rasplodnih svinja (nazimica, krmača i nerasta):
- Active immunity: The onset of immunity is from 3 weeks after basic vaccination.
- Aktivni imunitet: Imunitet se javlja od trećeg tjedna nakon primarnog cijepljenja.
MARKETING AUTHORISATION NUMBER(S) EU/2/98/009/001-006
EU/2/98/009/001-006
The immunity lasts for 3 months after basic vaccination.
Imunitet traje tri mjeseca nakon primarnog cijepljenja.
Progeny of vaccinated gilts and sows derive a passive immunity via the colostrum and milk.
Potomci cijepljenih nazimica i krmača stječu pasivan imunitet putem kolostruma i mlijeka.
SPECIAL STORAGE CONDITIONS Store and transport refrigerated (2 ºC - 8 ºC).
11. POSEBNI UVJETI ČUVANJA Čuvati i prevoziti na hladnom (2 ºC - 8 ºC).
Pharmacotherapeutic group: live Aujeszky's disease vaccine.
IMUNOLOŠKA SVOJSTVA Farmakoterapijska grupa: Živa vakcina bolesti Aujeszkoga
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
PROIZVOĐAČI BIOLOŠKI DJELATIH TVARI I PROIZVOĐAČI ODGOVORANI ZA PUŠTANJE SERIJE U PROMET
Accidental injection is dangerous - see package insert before use for further information and additional warnings.
POSEBNA UPOZORENJA, AKO JE POTREBNO Nehotično je injiciranje opasno - vidi uputu o VMP prije primjene za daljnje informacije i dodatna upozorenja.
Aluminium hydroxide Mineral oil (Marcol 52) Mannide mono oleate (Arlacel A) Polysorbate 80 (Tween 80) Thiomersal
Mineralno ulje (Marcol 52) Manid monooleat (Arlacel A) Polisorbat 80 (Tween 80) Tiomersal
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUTOVI PRIMJENE
By reconstitution of the immunogen in the oil emulsion, the stimulation of immunity after injection is prolonged.
Rekonstitucijom imunogena u uljnoj emulziji produljuje se stimulacija imuniteta nakon injekcije.
Shelf-life of the veterinary medicinal product as packaged for sale (solvent): 2 years.
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju (otapalo): 2 godine.
In general these reactions disappear within 3 weeks after the first vaccination.
Općenito, te se reakcije povlače unutar 3 tjedna nakon prvog cijepljenja.
• Inject one dose per breeding pigs (gilts, sows and boars) from the age of 10 weeks followed by a second injection 3-4 weeks after the first injection.
• Injicirati jednu dozu po rasplodnoj svinji (nazimice, krmače i nerasti) od 10 tjedana starosti nadalje, a 3 - 4 tjedna kasnije treba primijeniti drugu injekciju.
QUANTITY OF THE ACTIVE SUBSTANCE(S) Live attenuated Aujeszky's disease virus
KOLIČINA DJELATNE(IH) TVARI Živi, atenuirani virus bolesti Aujeszkoga
THE WORDS “KEEP OUT OF THE SIGHT AND REACH OF CHILDREN” Keep out of the sight and reach of children.
Čuvati izvan pogleda i dosega djece.
The active substance stimulates active immunity against Aujeszky's disease in pigs.
Djelatna tvar stimulira aktivni imunitet protiv bolesti Aujeszkoga kod svinja.
Aluminium hydroxide, Mineral oil (Marcol 52), Mannide mono oleate (Arlacel A), Polysorbate 80 (Tween 80), Thiomersal.
Aluminijev hidroksid, mineralno ulje (Marcol 52), manid monooleat (Arlacel A), polisorbat 80
To avoid foaming, shake gently the vial after reconstitution of the freeze-dried component in the liquid component.
Da se tekućina ne bi zapjenila, nakon rekonstitucije liofilizirane komponente u tekućoj komponenti bočicu tresite nježno.
Marketing authorisation holder: Zoetis Belgium SA Rue Laid Burniat 1
Zoetis Belgium SA Rue Laid Burniat 1
In general these reactions disappear within 3 weeks post primary vaccination.
Općenito, te se reakcije povlače unutar 3 tjedna nakon primarnog cijepljenja.
Name and address of the manufacturers of the biological active substances Zoetis Manufacturing & Research Spain, S.L.
Naziv i adresa proizvođača biološki djelatnih tvari Zoetis Manufacturing & Research Spain, S.L.
MANUFACTURER'S BATCH NUMBER Lot: {number} for the powder:
Serija: {broj} za prašak: Serija: {broj} za otapalo:
Solvent for emulsion for injection:
Otapalo za emulziju za injekciju:
Water for injections
Manitol Voda za injekcije
Cardboard box with 1 vial of powder and 1 bottle of solvent or 10 vials of powder and 10 bottles of solvent for injection.
6.5 Osobine i sastav unutarnjeg pakovanja Kartonska kutija s 1 bočicom praška i 1 bočicom otapala ili 10 bočica praška i 10 bočica otapala za injekciju.
INDICATION(S) Active and passive immunisation of pigs against Aujeszky's disease.
Aktivna i pasivna imunizacija svinja protiv bolesti Aujeszkoga.
SPECIAL WARNING(S) Accidental injection is dangerous - see package insert before use.
Nehotično je injiciranje opasno - vidi uputu o VMP prije primjene.
Name and address of the manufacturers responsible for batch release Zoetis Manufacturing & Research Spain, S.L.
Naziv i adresa proizvođača odgovornih za puštanje serije u promet Zoetis Manufacturing & Research Spain, S.L.
Excipient: Thiomersal
Tiomersal
Live attenuated Aujeszky's disease virus, strain NIA3-783: ≥ 105.2 CCID50* per 2 ml dose of reconstituted emulsion.
Živi, atenuirani virus bolesti Aujeszkoga, soj NIA3-783: ≥ 105,2 CCID50* po dozi od 2 ml rekonstituirane emulzije.
Shake gently to dissolve the vaccine and transfer the dissolved vaccine into the vial with the solvent.
Nježno protresite da bi se cjepivo rastopilo i premjestite rastopljeno cjepivo u bočicu s otapalom.
Powder for emulsion for injection:
Prašak za emulziju za injekciju:
Disodiumhydrogenphosphate Sodiumhydrogenphosphate Mannitol
Dinatrij-hidrogen-fosfat
WITHDRAWAL PERIOD Zero days.
Karencija: Nula dana.
Active substance
Djelatne tvari
ANNEX III LABELLING AND PACKAGE INSERT
OZNAČAVANJE I UPUTA O VMP
7-ml vials of Type I hydrolytic glass containing 10, 50 or 100 doses of freeze-dried powder.
I koje sadrže 10, 50 ili 100 doza liofiliziranog praška.
Disposal: read package leaflet.
Odlaganje: pročitati uputu o VMP
Active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus.
Aktivna imunizacija svinja od 10 tjedana starosti nadalje radi sprječavanja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER SUBSTANCE(S)
KVALITATIVNI I KVANTITATIVNI SASTAV DJELATNE(IH) TVARI I DRUGIH SASTOJAKA
20 ml, 100 ml or 200 ml bottles of Type I hydrolytic glass containing solvent for the 10-doses, 50doses or 100-doses presentation or Type II glass rinsed with WFI containing solvent for the 50-doses and 100-doses presentation.
20 ml, 100 ml ili 200 ml bočice od hidrolitičkog stakla tipa
METHOD AND ROUTE(S) OF ADMINISTRATION For intramuscular use of 1 dose (2 ml) per pig.
Za intramuskularnu primjenu 1 doze (2 ml) po svinji
Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus.
Pasivna imunizacija potomstva cijepljenih nazimica i krmača radi reduciranja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
Passive immunisation of piglets from vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's disease and to reduce the excretion of Aujeszky's disease field virus.
Pasivna imunizacija praščića cijepljenih nazimica i krmača radi reduciranja smrtnosti i kliničkih znakova bolesti Aujeszkoga i reduciranja lučenja terenskog virusa bolesti Aujeszkyoga.
Manufacturer responsible for the batch release: Zoetis Manufacturing & Research Spain, S.L.
Zoetis Manufacturing & Research Spain, S.L.
1 vial with powder for injection (10 doses) and 1 bottle of solvent for injection (20 ml).
1 bočica s praškom za injekciju (10 doza) i 1 bočica otapala za injekciju (20 ml).
PHARMACEUTICAL FORM Powder and solvent for emulsion for injection
Prašak i otapalo za emulziju za injekciju
The manufacture, import, possession, sale, supply and/or use of Suvaxyn Aujeszky 783 + O/W may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Uvoz, proizvodnja, uvoz, posjedovanje, prodaja, opskrba i/ili primjena Suvaxyn Aujeszky 783 + O/W
1 vial with powder for injection (100 doses) and 1 bottle of solvent for injection (200 ml).
1 bočica s praškom za injekciju (100 doza) i 1 bočica otapala za injekciju (200 ml).
1 vial with powder for injection (50 doses) and 1 bottle of solvent for injection (100 ml).
1 bočica s praškom za injekciju (50 doza) i 1 bočica otapala za injekciju (100 ml).
Powder:
Otapalo:
50 doses
10 doza 50 doza 100 doza
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
17. BROJ PROIZVODNE SERIJE PROIZVOĐAČA
10 vials with powder for injection (each containing 50 doses) and 10 bottles of solvent for injection (each containing 100 ml).
10 bočica s praškom za injekciju (svaka sadrži 50 doza) i 10 bočica otapala za injekciju (svaka sadrži
PACKAGE LEAFLET Suvaxyn Aujeszky 783 + O/W, powder and solvent for emulsion for injection for pigs
Suvaxyn Aujeszky 783 + O/W, prašak i otapalo za emulziju za injekciju za svinje
10 vials with powder for injection (each containing 100 doses) and 10 bottles of solvent for injection (each containing 200 ml).
10 bočica s praškom za injekciju (svaka sadrži 100 doza) i 10 bočica otapala za injekciju (svaka sadrži
Luxembourg/ Luxemburg Zoetis Belgium SA Tél/Tel.
Luxembourg/ Luxemburg
10 vials with powder for injection (each containing 10 doses) and 10 bottles of solvent for injection (each containing 20 ml).
10 bočica s praškom za injekciju (svaka sadrži 10 doza) i 10 bočica otapala za injekciju (svaka sadrži
NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn Aujeszky 783 + O/W, powder and solvent for emulsion for injection for pigs
UPUTA O VMP ZA: Suvaxyn Aujeszky 783 + O/W, prašak i otapalo za emulziju za injekciju za svinje.
This should be carried out by healthcare professionals.
To trebaju činiti zdravstveni radnici.
ATC code: A10AB01.
ATK oznaka: A10AB01.
Date of latest renewal: 18 September 2007
Datum posljednje obnove odobrenja: 18. rujna 2007.
This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).
To može predstavljati rizik u situacijama u kojima su takve sposobnosti posebno važne (primjerice, vožnja automobila ili rukovanje strojevima).
Trials have indicated a t½ of about 2-5 hours.
Ispitivanja su pokazala da t½ iznosi približno 2-5 sati.
• Drink alcohol, see Actrapid with alcohol in section 2.
• pijete alkohol, pogledajte Actrapid s alkoholom u dijelu 2.
Actrapid will start to lower your blood sugar about half an hour after you inject it, and the effect will last for approximately 8 hours.
Actrapid će početi snižavati razinu šećera u krvi oko pola sata nakon što ga injicirate, a učinak će trajati približno 8 sati.
The data are limited but suggest that the pharmacokinetic profile in children and adolescents may be similar to that in adults.
Podaci su ograničeni, ali upućuju na to da bi farmakokinetički profil u djece i adolescenata mogao biti sličan onomu u odraslih.
Actrapid which has been frozen must not be used.
Actrapid koji je bio zamrznut ne smije se primijeniti.
Although stable over time, a certain amount of insulin will initially be adsorbed to the material of the infusion bag.
Iako je stabilan tijekom vremena, određena količina inzulina inicijalno će se adsorbirati na materijal infuzijske vrećice.
Date of first authorisation: 07 October 2002
Datum prvog odobrenja: 7. listopada 2002.
You must never inject yourself directly into a vein (intravenously) or muscle (intramuscularly).
Nikada si ne smijete dati injekciju izravno u venu (intravenski) ili mišić (intramuskularno).
After stabilisation of the patient's blood glucose, adjustment of the dose should be considered (see sections 4.8 and 4.9).
Nakon što u bolesnika dođe do stabilizacije glikemije treba razmotriti prilagodbu doze (vidjeti dijelove 4.8 i 4.9).
The maximum plasma concentration is reached within 1.5-2.5 hours after subcutaneous administration.
Maksimalna koncentracija u plazmi postiže se unutar 1,5-2,5 sata nakon supkutane primjene.
Onset of action is within ½ hour, reaches a maximum effect within 1.5-3.5 hours and the entire duration of action is approximately 7-8 hours.
Počinje djelovati unutar ½ sata, maksimalni učinak postiže se unutar 1,5-3,5 sata, dok ukupno trajanje djelovanja iznosi približno 7-8 sati.
A number of cleavage (hydrolysis) sites on the human insulin molecule have been proposed; none of the metabolites formed following the cleavage are active.
Predložena su brojna mjesta cijepanja (hidrolize) molekule humanog inzulina; niti jedan od metabolita nastalih nakon cijepanja nije aktivan.
Actrapid dosing is individual and determined in accordance with the needs of the patient.
Doziranje lijeka Actrapid individualno je i određuje se u skladu s potrebama bolesnika.
Actrapid with alcohol
Actrapid s alkoholom
The pharmacokinetic profile of Actrapid has been studied in a small number (n=18) of diabetic children (aged 6-12 years) and adolescents (aged 13-17 years).
Farmakokinetički profil lijeka Actrapid ispitan je u malog broja (n=18) djece (u dobi od 6-12 godina) i adolescenata (u dobi od 13-17 godina) sa šećernom bolešću.
• Screw the needle straight and tightly onto your InnoLet (picture 1A).
• Navijte iglu ravno i čvrsto na InnoLet (slika 1A).
What Actrapid is and what it is used for
Što je Actrapid i za što se koristi
What Actrapid looks like and contents of the pack
Kako Actrapid izgleda i sadržaj pakiranja
However, there were differences between age groups in Cmax, stressing the importance of individual dose titration.
Ipak, zabilježene su razlike između dobnih skupina s obzirom na Cmax, što naglašava važnost individualne titracije doze.
This should be kept in mind if treatment with the combination of pioglitazone and Actrapid is considered.
Ovo treba imati na umu ako se razmatra liječenje kombinacijom pioglitazona i lijeka Actrapid.
Withdraw the needle from the skin, then release the pressure on the push-button.
Izvucite iglu iz kože, a zatim otpustite potisni gumb.
Due to the risk of precipitation in pump catheters, Actrapid should not be used in insulin pumps for continuous subcutaneous insulin infusion.
Zbog opasnosti od precipitacije u kateterima pumpe, Actrapid se ne smije koristiti u inzulinskim pumpama za kontinuiranu supkutanu infuziju inzulina.
Actrapid is used to reduce the high blood sugar level in patients with diabetes mellitus (diabetes).
Actrapid se koristi za snižavanje visoke razine šećera u krvi u bolesnika s dijabetesom (šećernom bolešću).
If necessary Actrapid can be given directly into a vein, but this must only be done by healthcare professionals.
Ako je potrebno, Actrapid se može dati izravno u venu, ali to smije učiniti samo zdravstveni radnik.